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Abstract
Henipaviruses, Hendra virus (HeV) and Nipah virus (NiV), have Pteropid bats as their known natural reservoirs. Antibodies
against henipaviruses have been found in Eidolon helvum, an old world fruit bat species, and henipavirus-like nucleic acid
has been detected in faecal samples from E. helvum in Ghana. The initial outbreak of NiV in Malaysia led to over 265 human
encephalitis cases, including 105 deaths, with infected pigs acting as amplifier hosts for NiV during the outbreak. We
detected non-neutralizing antibodies against viruses of the genus Henipavirus in approximately 5% of pig sera (N=97)
tested in Ghana, but not in a small sample of other domestic species sampled under a E. helvum roost. Although we did not
detect neutralizing antibody, our results suggest prior exposure of the Ghana pig population to henipavirus(es). Because a
wide diversity of henipavirus-like nucleic acid sequences have been found in Ghanaian E. helvum, we hypothesise that these
pigs might have been infected by henipavirus(es) sufficiently divergent enough from HeVor NiV to produce cross-reactive,
but not cross-neutralizing antibodies to HeV or NiV.
Citation: Hayman DTS, Wang L-F, Barr J, Baker KS, Suu-Ire R, et al. (2011) Antibodies to Henipavirus or Henipa-Like Viruses in Domestic Pigs in Ghana, West
Africa. PLoS ONE 6(9): e25256. doi:10.1371/journal.pone.0025256
Editor: Welkin E. Johnson, Harvard Medical School, United States of America
Received July 4, 2011; Accepted August 30, 2011; Published September 22, 2011
Copyright:  2011 Hayman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was funded by the The Wellcome Trust (to DTSH, KSB), Defra grant VT0105, the RAPIDD program of the Science and Technology Directorate,
Department of Homeland Security, and Fogarty International Center, National Institutes of Health (NIH), and NIH grant AI077995. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dtsh2@cam.ac.uk
Introduction
The genus Henipavirus in the family Paramyxoviridae is comprised
of Hendra (HeV) and Nipah (NiV) viruses. These viruses use bats
of the family Pteropodidae as their natural reservoir hosts [1,2].
Henipaviruses have a remarkably wide susceptible host range and
represent some of the most pathogenic viruses known, each
capable of causing an often fatal encephalitis or severe respiratory
disease and both are classified as biosafety level 4 pathogens.
Outbreaks of NiV in Malaysia, India and Bangladesh have had
case fatality rates ranging from 40–90% [3,4,5]. The Malaysian
NiV epidemic led to over 265 human encephalitis cases, with 105
deaths [4]. To date, two domestic species are known to have
served as amplifying hosts for henipaviruses prior to transmission
to humans; horses for HeV and pigs for NiV. Infected pigs acted as
amplifier hosts for NiV during the Malaysian NiV outbreak, and
over one million pigs were culled to contain the epidemic [6,7].
Furthermore, both cats and dogs have been found to be positive
(NiV-cats) or seropositive (NiV and HeV-dogs) [7,8].
We previously reported serological evidence for henipavirus
infection in Eidolon helvum bats in Ghana, West Africa [9]. Eidolon
helvum roosts in large colonies, reaching several million in number,
and has a wide distribution across the African continent. Those
findings thus extended the range of henipaviruses from Asia and
Australasia to Africa. A subsequent study found henipavirus-like
nucleic acid in faecal samples from E. helvum in Ghana [10]. We
therefore hypothesised that domestic animal species that have
previously acted as amplifier hosts elsewhere may have been
exposed to henipavirus infection in Africa.
To test this hypothesis, we screened a selection of domestic
animal sera from animals within the grounds of the 37 Military
Hospital, Accra, Ghana, where a large E. helvum colony (up to 1
million individual animals) resides for approximately 6 months
during each dry season.
Methods
Ethical approval for this project (WLE/0467) was received from
the Zoological Society of London Ethics Committee and locally
from the Ghanaian Veterinary Services Directorate. Serum
samples were collected in June 2007 from 2 cats, 2 dogs, 10
sheep and 15 goats. In addition, 97 pig samples were available
from 2 villages, collected as part of a Trypanosoma study undertaken
at the Veterinary Services Laboratory, Ghana. Both villages are in
the Suhum/Kraboa/Coalta district, Eastern Region, about 70 km
north of Accra. Sample numbers P1–48 and P50 were from 25
households in Kwesikonfo (N 6u33; W 0u 33) and P52–64 and
P66–100 from 11 households in Zorh (N 5u59 W 0u21). The bat-
pig contact history was unknown. However, villages contain fruit
trees and the pigs were housed in open pens (1–10/pen), with
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have been caught by the authors foraging in other villages in the
region [9,11].
All sera were tested for antibodies binding to both a HeV and
NiV recombinant soluble G glycoprotein (sG) using a LuminexH
multiplexed binding assay, as described previously [9,12]. Viral
envelope glycoproteins have previously been demonstrated to be
the primary protein for paramyxovirus attachment and virus
entry, and also the principle viral antigens that inducer
neutralizing antibodies in hosts [13]. The recombinant sG proteins
used in the Luminex assay were generated using a mammalian
expression system in a soluble and oligomeric form by removing
the transmembrane domain, and purified sG was coupled to
microspheres as described previously [12]. For all test samples
sGNiV and sGHeV-coupled microsphere subsets were pre-mixed
and incubated with sera, followed by incubation with biotinylated
Protein A/G and streptavidin–phycoerythrin. Antibodies bound to
the sGNiV or sGHeV coated beads, which are spectrally distinct, are
quantified by the fluorescence emitted by phycoerythrin. This is
read as the median fluorescence intensity (M.F.I.). Gamma-
irradiated positive pig and cat sera controls from naturally or
experimentally infected animals, and negative controls from each
species were used. Putative positive sera, with M.F.I. titres 3-fold
above the negative sera M.F.I., were then tested using a Luminex
ephrin-B2 receptor blocking (inhibition) assay and by virus
neutralization tests (VNTs) [12]. Field samples of HeV infected
horse and NiV infected pig sera has previously been demonstrated
to block ephrin-B2-G glycoprotein interactions in a dose
dependent fashion [12]. For the VNTs, sera were tested against
both NiV and HeV at a 1:10 dilution.
Finally, 7 pig sera with high Luminex binding titres, and 1 with
a low Luminex binding titre (P17) were tested by western blot
(WB). The WB was performed using purified recombinant Nipah
virus nucleocapsid (N) protein produced as previously described
[14]. Briefly, 50mg of purified NiV N protein was separated using
SDS-PAGE on a 12% gel using a wide preparative comb, followed
by electroblotting onto a nitrocellulose membrane and blocked
overnight in blocking buffer (5% w/v Skim Milk Powder in TBS
buffer). The nitrocellulose membrane was cut into strips and
incubated for 1h with individual sera (diluted 1:50 in blocking
buffer). Negative controls were a negative pig serum and blocking
buffer alone, with NiV-neutralizing human and pig sera as positive
controls. Following washing, the strips were incubated for 1h with
a protein A/G alkaline phosphatase conjugate (Thermo-Fisher
Scientific Inc., USA) at 1:2000 in blocking buffer. Following
washing, alkaline phosphatase substrates were added and allowed
to develop for 15 minutes. The marker used was Benchmark
prestained protein ladder (Invitrogen, UK).
Results
One goat (G)and one sheep (S) sample eachhad M.F.I. titres well
above 3 times background for NiV and HeV respectively. G159s
titre was 584 M.F.I. against NiV (.3 times mean negative sera
M.F.I. of 62), but only produced a titre of 71.5 M.F.I. against HeV
(negative sera M.F.I. 62). Sheep S79s M.F.I. titre was 521 against
HeV(.3 timesmeannegative seraM.F.I.of81), butonly 86 M.F.I.
against NiV (negative sera M.F.I. 66) (see Figure 1). Neither these,
nor 4 further goat and 1 further sheep sera tested, were positive
using the inhibition assay. Pig sera were tested in 2-sample pools
(N=74 samples) or individually (N=23) (see Figure 2). Inhibition
was then tested on individual samples for those with high binding
readings (see Figure 3). Of those tested, 5/18 (5.2% of the total pig
sera) had high levels (.20%) of inhibition. Sample P29 gave 74%
inhibition. This is high and comparable to the NiV-positive pig
control inhibition of 90%. P29 was one of a pool of sera tested with
another sample by Luminex sG binding, and therefore diluted 1:2
Figure 1. The M.F.I. of anti-NiV (Red) and HeV (Blue) antibodies
from 2 cats (C), 2 dogs (D), 10 sheep (S) and 15 goats (G) from
Ghana with NiV positive cat and negative (all species) control.
doi:10.1371/journal.pone.0025256.g001
Figure 2. The median fluorescent intensities (M.F.I.) of 97 pig (P) sera from Ghana tested in pools of 2 or singly for antibodies
against Nipah (NiV-Red) and Hendra (HeV-Blue) virus soluble glycoprotein (sG) attached to microspheres on the Luminex platform.
Positive and negative serum controls are shown.
doi:10.1371/journal.pone.0025256.g002
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to a NiV positive pig titre of 6043 M.F.I.
All sera tested for inhibition (5 goat, 2 sheep and 18 pig) were
tested by VNTs, but no sera tested positive using VNTs. However,
one (P92) of the seven binding-antibody positive pig sera tested
positive by WB against the N protein (Figure 4), thus confirming
non-neutralizing antibody against another NiV protein. No
further sample was available for P29 for testing by WB. The
additional WB staining seen in all samples except P92 is thought to
be non-specific background staining.
Discussion
Our results suggest evidence of prior exposure of the Ghana pig
population to henipavirus(es). The wide diversity of henipavirus-
like nucleic acid sequences that have been found in Ghanaian bats
[10] means that it is possible that these pigs have been infected by
henipavirus(es) divergent enough from HeV or NiV to produce
glycoprotein binding antibodies, but not HeV or NiV neutralizing
antibodies [15].
Luminex binding assay has been demonstrated to give
preferentially higher M.F.I. for the virus that induced antibody
from field sera of NiV infected pigs from the 1998–1999 NiV
outbreak in Malaysia and Singapore, and HeV infected horses
from the 1994 HeV outbreak [12]. While it is possible that the
positive results found against both virus sG in this study are due to
broad high background binding, the lack of this finding in
Malaysian pig sera from the 1998–1999 outbreak and the
relatively high inhibition of ephrin-B2-G glycoprotein interactions
(Figure 3) are suggestive of previous exposure to henipaviruses. In
addition to this, binding was confirmed on another platform, WB,
and against another protein (N) by a single serum sample. This
sample (P92) had demonstrated 40% sG-Ephrin B2 receptor
inhibition and had a Luminex binding M.F.I. titre 27-fold higher
than the negative pig control serum. Although the non-specific
staining by other positive sera is undesirable, pig sera have been
shown previously to be reactive for non-specific stains, particularly
to E. coli proteins. However, given binding antibody had
previously been demonstrated against sG NiV proteins in this
sample of pig sera, we believe this adds further evidence of
infection by a NiV or Nipah-related virus in these populations.
The mechanisms of virus neutralization are complex and could
involve more antigenic sites than those required for simple receptor
binding or inhibition. The failure of finding VNT positive sera
therefore may be due to the divergent nature of the viruses inducing
antibody. As has been shown in studies on bats in Ghana, only a
relatively small proportion of those seropositive by Luminex assay
were VNT positive, and subsequent studies by others have shown
related but divergent henipavirus sequences from the same bat
species. Furthermore, previous studies have shown the NiV
antibody positive pig sera produced lower titres than human
(NiV, HeV), bat (HeV) and horse (HeV) positive sera using all three
(binding, receptor inhibition and neutralization) assays [12].
Laboratory studies suggest viral replication in bats is limited
[16,17] and bat-to-human transmission outside of Bangladesh is
yet to be reported. Therefore, evidence of infection in potential
amplifying hosts in Ghana is an important finding, whether due to
multiple introductions or a single introduction of infection with
subsequent pig-to-pig transmission. It is unknown which is the
cause of the Ghanaian pig serological results here, however, both
are important events that may lead to henipavirus emergence by
altering infection dynamics within the populations on subsequent
re-introduction [18]. Further sera from these animals are
unavailable for additional testing; however, future sampling should
be age-specific in order to make inferences relating to infection
dynamics in the pig populations.
Finally, E. helvum frequently roosts in urban areas, is a source of
bushmeat [9,11] and is known to forage in semi-urban areas [19],
and we are therefore currently increasing the study size and
extending it to include humans and animals in high risk groups of
exposure to bats in order to determine the likelihood of exposure
to potentially-fatal zoonotic viruses.
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Figure 3. Percentage inhibition of NiV and HeV sG-Ephrin-B2
receptor by Luminex binding assay positive pig (P) sera, with
NiV positive and negative controls.
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Figure 4. The results of western blot analysis against Nipah
virus nucleocapsid protein of seven Ghanaian pig sera
(designated P) with high Luminex binding assay titres and
one (P17) with a low binding assay titre against soluble
henipavirus glycoproteins. The marker is BenchMark Pre-stained
Protein Ladder (Invitrogen); the positive sera NiV virus neutralization
test positive pig and human field sera; the negative control sera
negative pig and skimmed milk powder (SMP).
doi:10.1371/journal.pone.0025256.g004
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